ASSOCIATION BETWEEN PROSTHETIC JOINT INFECTION AND MORTALITY FOLLOWING PRIMARY TOTAL HIP ARTHROPLASTY

Prosthetic joint infection (PJI) remains a dreaded and unpredictable complication after total hip arthroplasty (THA). In addition to causing significant morbidity, PJI may contribute to long-term mortality risk. Our objective was to determine the long-term mortality risk associated with PJI after THA. We conducted a population-based retrospective cohort study of adult patients (age > 18 years) in Ontario, Canada who underwent primary elective total hip arthroplasty for arthritis between April 1, 2002 and March 31, 2021. Main outcomes were death within ten years of index joint replacement. Outcomes were compared for propensity-score matched groups (PJI within one year of surgery versus no-PJI within one year of surgery), using survival analyses. Patients who died within one year of surgery were excluded to avoid immortal-time bias. A secondary analysis was performed solely in patients who had a PJI within one year of THA to identify predictors of death within ten years. A total of 175,432 patients (mean [SD] age 67 [11.4] years; 95,883 (54.7%) women) had a total hip replacement during the study period. Of these, 868 patients (0.49%) underwent surgery for a PJI of the replaced joint within one year of their index procedure. After matching, patients who had an infection in the first year had a significantly higher ten-year mortality rate (94 [11.4%] vs 18 [2.2%]; absolute risk difference (RD) 9.19% [95% Confidence interval (CI) 6.81%-11.6%]; HR 5.49 [95% CI 3.32-9.09]) (Figure 1). Among those with PJI, factors associated with greater risk of mortality were COPD (HR 3.85, p Prosthetic joint infection within a year of surgery is associated with over a 5-fold increased ten-year risk of mortality. Among those with PJI, risk of mortality was further increased by COPD, diabetes with complications, liver disease, and frailty. The findings of this study underscore the importance of prioritized efforts relating to the prevention, diagnosis, and treatment of PJIs. For any figures or tables, please contact the authors directly.

Authors

Publication Details

Journal
Orthopaedic Proceedings
Published
2025-11-14
DOI
https://doi.org/10.1302/1358-992x.2025.13.069
Primary Topic
Orthopedic Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ASSOCIATION BETWEEN PROSTHETIC JOINT INFECTION AND MORTALITY FOLLOWING PRIMARY TOTAL HIP ARTHROPLASTY

Seper Ekhtiari, Bheeshma Ravi, Donald A. Redelmeier, Raman Mundi et al.
Orthopaedic Proceedings
Orthopedic Infections and Treatments
article

ASSOCIATION BETWEEN PROSTHETIC JOINT INFECTION AND MORTALITY FOLLOWING PRIMARY TOTAL HIP ARTHROPLASTY

Seper Ekhtiari, Bheeshma Ravi, Donald A. Redelmeier, Raman Mundi, Harman Chaudhry, Michael J. Paterson, E. Schemitsch, David W. Pincus, J. Leir
article en

Abstract

Prosthetic joint infection (PJI) remains a dreaded and unpredictable complication after total hip arthroplasty (THA). In addition to causing significant morbidity, PJI may contribute to long-term mortality risk. Our objective was to determine the long-term mortality risk associated with PJI after THA. We conducted a population-based retrospective cohort study of adult patients (age > 18 years) in Ontario, Canada who underwent primary elective total hip arthroplasty for arthritis between April 1, 2002 and March 31, 2021. Main outcomes were death within ten years of index joint replacement. Outcomes were compared for propensity-score matched groups (PJI within one year of surgery versus no-PJI within one year of surgery), using survival analyses. Patients who died within one year of surgery were excluded to avoid immortal-time bias. A secondary analysis was performed solely in patients who had a PJI within one year of THA to identify predictors of death within ten years. A total of 175,432 patients (mean [SD] age 67 [11.4] years; 95,883 (54.7%) women) had a total hip replacement during the study period. Of these, 868 patients (0.49%) underwent surgery for a PJI of the replaced joint within one year of their index procedure. After matching, patients who had an infection in the first year had a significantly higher ten-year mortality rate (94 [11.4%] vs 18 [2.2%]; absolute risk difference (RD) 9.19% [95% Confidence interval (CI) 6.81%-11.6%]; HR 5.49 [95% CI 3.32-9.09]) (Figure 1). Among those with PJI, factors associated with greater risk of mortality were COPD (HR 3.85, p Prosthetic joint infection within a year of surgery is associated with over a 5-fold increased ten-year risk of mortality. Among those with PJI, risk of mortality was further increased by COPD, diabetes with complications, liver disease, and frailty. The findings of this study underscore the importance of prioritized efforts relating to the prevention, diagnosis, and treatment of PJIs. For any figures or tables, please contact the authors directly.

Orthopaedic ProceedingsVol. 107-B(SUPP_13)
Openalex Percentile: Top 47%
Orthopedic Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.